Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$566K Buy
4,403
+354
+9% +$41.4K 0.1% 123
2026
Q1
$487K Buy
4,049
+837
+26% +$96.6K 0.11% 106
2025
Q4
$338K Buy
3,212
+582
+22% +$54.6K 0.08% 138
2025
Q3
$221K Buy
+2,630
New +$217K 0.06% 189
2025
Q1
Sell
-3,448
Closed -$343K 187
2024
Q4
$343K Buy
3,448
+1,200
+53% +$124K 0.13% 76
2024
Q3
$221K Sell
2,248
-649
-22% -$77.1K 0.08% 134
2024
Q2
$360K Buy
2,897
+684
+31% +$88.1K 0.15% 67
2024
Q1
$288K Buy
+2,213
New +$273K 0.13% 77

Other funds holding MRK

EWA LLC's MRK Position: Q2 2026 in Review

EWA LLC increased its Merck (MRK) stake by 8.7% in Q2 2026, buying an estimated $41.4K and bringing the position to 4,403 shares worth $566K. The position accounts for 0.1% of the portfolio, ranked #123.

EWA LLC first reported a position in MRK in Q1 2024 and has held it in 8 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • EWA LLC held 4,403 shares of Merck worth $566K as of Q2 2026.
  • EWA LLC bought 354 Merck shares in Q2 2026, an estimated $41.4K.
  • Merck made up 0.1% of EWA LLC's portfolio in Q2 2026, its #123 holding.
  • EWA LLC first reported a position in Merck in Q1 2024 and has held it in 8 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.